MENU
CYTK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cytokinetics (CYTK) Earnings Date & Reports

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

CYTK is expected to report earnings to fall 38.43% to -157 cents per share on March 04

Cytokinetics CYTK Stock Earnings Reports
Q4'25
Est.
$-1.57
Q3'25
Missed
by $0.98
Q2'25
Beat
by $0.30
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.04
The last earnings report on November 05 showed earnings per share of -254 cents, missing the estimate of -157 cents. With 772.79K shares outstanding, the current market capitalization sits at 8.06B.
View a ticker or compare two or three
CYTK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CYTK showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company which engages in discovery and development of small molecule drug therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
350 Oyster Point Boulevard
Phone
+1 650 624-3000
Employees
564
Web
https://www.cytokinetics.com